About
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 6 investors are based in Planegg, Bayern, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Planegg, Germany
Find more investors like 4SC
Search Investors